Target intelligence / Profile preview

Colonization factor antigen I minor subunit E (CfaE)

Target
CfaE
Molecular classification
Adhesin, Fimbrial protein (pilin-related), Bacterial virulence factor, Other
01

Overview

Colonization factor antigen I minor subunit E (CfaE) is the tip-localized adhesive subunit of the colonization factor antigen I (CFA/I) fimbria, a virulence structure of enterotoxigenic Escherichia coli (ETEC), one of the most common causes of diarrhea in children and travelers[3][6]. CFA/I fimbriae are rigid, rod-like appendages consisting mainly of major subunit CfaB, with a few copies of CfaE at the tip where it is essential for mediating attachment to specific receptors on intestinal epithelial cells and erythrocytes[3][4][6][7][8]. CfaE is assembled via the chaperone-usher pathway and its function is necessary for bacterial colonization of the human small intestine[3][5][6]. Structurally, CfaE contains an N-terminal adhesin domain and a C-terminal pilin domain, with the adhesin domain carrying the receptor-binding activity[6][8]. Mutation studies have shown that specific residues in CfaE are required for receptor binding, highlighting its essential and specific role in pathogenesis[4][6][8]. CfaE has no endogenous human role and is not a human protein; it is a prime candidate for anti-infective strategies aiming to block ETEC colonization by vaccines or neutralizing agents, though no approved drugs currently target CfaE directly[3][6][7].

Other names
CFA/I fimbrial subunit ECfaE adhesinCfaE tip adhesin
02

Mechanism of action

Inhibition of host-pathogen adhesion by blocking the CfaE–host receptor interaction; Neutralization of bacterial attachment to the gut epithelium via antibodies or competitive antagonists

03

Biological functions

Adhesion to host intestinal epithelial cellsInitiation of fimbrial assemblyBacterial colonization of the gut
04

Disease associations

Infection (specifically, diarrheal disease caused by enterotoxigenic Escherichia coli)
05

Safety considerations

Targeting this molecule must avoid off-target effects on human glycan-binding proteinsAntigenic variability between ETEC strains may challenge vaccine or inhibitor efficacy
06

Interacting drugs

None approved; research on anti-adhesive vaccines, antibodies, and small-molecule inhibitors in preclinical or early clinical studies
07

Biomarkers

Expression of CfaE as a marker of CFA/I-positive ETEC strainsAnti-CfaE antibody levels as potential markers of exposure or vaccine efficacy

Beyond the preview

Go deeper on Colonization factor antigen I minor subunit E (CfaE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonization factor antigen I minor subunit E (CfaE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call